A cell-permeable, selective inhibitor of SIRT2 (IC₅₀ = 3.5 μM) that minimally affects either SIRT1 or SIRT3; rescues dopamine neurons from α-synuclein toxicity in both in vitro and in vivo Parkinson’s disease models.